About ADvantage Therapeutics
ADvantage Therapeutics is a private company based in Miami, Florida, incorporated in 2021 in Delaware. It has reported $19,012,491 raised in three offerings on Form D since June 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 28, 2023 | Jul 12, 2023amended Jul 28, 2025 | $13,737,491of $25.4M target | 24 | $572K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| May 31, 2022 | Jun 15, 2022 | $275,000of $7.5M target | 3 | $91,667 | OptionsRule 506(b) | Form D ↗ |
| Jun 10, 2021 | Jun 24, 2021 | $5,000,000of $10.0M target | 1 | $5.0M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $19,012,491 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on ADvantage Therapeutics's Form D filed Jul 28, 2025.
WS
AI
Agustin Fernandez Santana III
Executive officer and director
Also an executive officer and director at Klothea BIO.
JM
DB
David Buchsbaum
Chief Financial Officer
FM
Frank Mattner
Director